Chimerix
Chimerix is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Chimerix products.
Drugs from Chimerix supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Modeyso | dordaviprone | Oncology (Rare CNS) | Diffuse midline glioma with H3 K27M mutation |
How NPP access to Chimerix products works
Reserve Meds sources Chimerix products from a US-licensed pharmaceutical wholesale partner, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Chimerix
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Chimerix.